Department News

In the 5-year follow-up of the pivotal SOLO-1 trial in women with advanced ovarian cancer and a BRCA1/2 mutation, maintenance treatment with olaparib led to a doubling in progression-free survival. William H. Bradley, MD, presented these findings at the Society of Gynecologic Oncology (SGO) 2021...

We are pleased to announce the appointment of Kate Dielentheis, MD as the Director of OBGYN Faculty Development. Kate will provide leadership on learner education programs, assessments and coordination in addition to the faculty development series....